| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |